Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 6Unknown 3Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 4Breast Neoplasms 4Stomach Neoplasms 2Rectal Neoplasms 2Pancreatic Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Triple Negative Breast Neoplasms 1Peritoneal Neoplasms 1Neoplastic Cells, Circulating 1Neoplasms 1Neoplasm, Residual 1Nasopharyngeal Carcinoma 1NSCLC 1Melanoma 1HER2 Negative Breast Cancer 1Carcinoma, Ovarian Epithelial 1

Interventions

Paclitaxel 10Carboplatin 6Bevacizumab 5pembrolizumab 4Cyclophosphamide 4olaparib 3liposomal doxorubicin 3fludarabine 3ribociclib 2palbociclib 2mirvetuximab soravtansine 2Topotecan 2Nivolumab 2Letrozole 2Fulvestrant 2Blood Specimen Collection 2trastuzumab deruxtecan 1sacituzumab govitecan 1pegfilgrastim 1niraparib 1lenvatinib 1isoquercitrin 1fludarabine phosphate 1durvalumab 1cemiplimab 1abemaciclib 1Tinzaparin 1Surveys and Questionnaires 1Surgical Procedures, Operative 1SLC25A33 protein, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Carcinoma, Ovarian Epithelial × Chemotherapy, Adjuvant × Clear all
NCT04063527 2019-08-30

Phase III Trial of Stage I Ovarian Cancer After Surgery

Japanese Gynecologic Oncology Group

Phase 3 Recruiting
360 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡